{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:54:49Z","timestamp":1793836489312,"version":"4.6.1"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.parkreldis.2016.11.012","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T08:18:56Z","timestamp":1479889136000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Oculogyric crises: Etiology, pathophysiology and therapeutic approaches"],"prefix":"10.1016","volume":"36","author":[{"given":"Ewgenia","family":"Barow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash P.","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Ganos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2016.11.012_bib1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.39.11.1434","article-title":"Tardive oculogyric crises","volume":"39","author":"FitzGerald","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/B978-0-444-53488-0.00036-5","article-title":"Encephalitis lethargica (von Economo's encephalitis)","volume":"123","author":"Berger","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.1961.03040120016004","article-title":"A\u00a0survey of drug-induced extrapyramidal reactions","volume":"175","author":"Ayd","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(11)70141-7","article-title":"The monoamine neurotransmitter disorders: an expanding range of neurological syndromes","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/WNL.52.8.1714","article-title":"Oculogyric crisis as an initial manifestation of Wilson's disease","volume":"52","author":"Lee","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib6","first-page":"48","article-title":"Oculogyric crisis associated with disulfiram-induced pallidonigral lesion","volume":"2","author":"Lee","year":"2009","journal-title":"J.\u00a0Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/jnnp.50.3.365","article-title":"Oculogyric crisis in acute herpetic brainstem encephalitis","volume":"50","author":"Matsumura","year":"1987","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mds.870080117","article-title":"Tardive and chronically recurrent oculogyric crises","volume":"8","author":"Sachdev","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/mds.22532","article-title":"Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs","volume":"24","author":"Schneider","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JCP.0000000000000411","article-title":"Incidence of oculogyric crisis and long-term outcomes with second-generation antipsychotics in a first-episode psychosis program","volume":"35","author":"Gardner","year":"2015","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/15622970500222443","article-title":"Psychiatric symptoms associated with oculogyric crisis: a review of literature for the characterization of antipsychotic-induced episodes","volume":"7","author":"Abe","year":"2006","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.410220106","article-title":"Oculogyric crisis: a syndrome of thought disorder and ocular deviation","volume":"22","author":"Leigh","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.164.1.115","article-title":"Acute dystonic reactions complicated by psychotic phenomena","volume":"164","author":"Thornton","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(70)92572-9","article-title":"L-dopa and oculogyric crises","volume":"2","author":"Sacks","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/WNL.36.5.606","article-title":"The lateralizing significance of versive head and eye movements during epileptic seizures","volume":"36","author":"Wyllie","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mds.870060309","article-title":"Dystonic tics in patients with Tourette's syndrome","volume":"6","author":"Jankovic","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejpn.2012.04.004","article-title":"Paroxysmal tonic upgaze in normal children: a case series and a review of the literature","volume":"16","author":"Salmina","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.psc.2004.10.004","article-title":"Neuroleptic-induced movement disorders: an overview","volume":"28","author":"Sachdev","year":"2005","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00004714-198710000-00011","article-title":"Prediction of neuroleptic-induced dystonia","volume":"7","author":"Keepers","year":"1987","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib20","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1176\/ajp.132.5.532","article-title":"Drug-induced dystonia","volume":"132","author":"Swett","year":"1975","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib21","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1176\/ajp.151.12.1819","article-title":"Predictors of acute dystonia in first-episode psychotic patients","volume":"151","author":"Aguilar","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib22","first-page":"81","article-title":"Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia","volume":"28","author":"Chakos","year":"1992","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/OPTH.S60041","article-title":"Oculogyric crisis in a patient taking metoclopramide","volume":"8","author":"Koban","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00006324-198903000-00009","article-title":"Oculogyric crisis after metoclopramide therapy","volume":"66","author":"Edwards","year":"1989","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/01.smj.0000232971.27692.0f","article-title":"A\u00a0case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis","volume":"99","author":"Lou","year":"2006","journal-title":"South Med. J."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5152\/eajm.2013.10","article-title":"Metoclopramide-induced acute dystonic reaction: a case report","volume":"45","author":"Karagoz","year":"2013","journal-title":"Eurasian J. Med."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/0253-7613.93867","article-title":"Metoclopramide-induced oculogyric crisis presenting as encephalitis in a young girl","volume":"44","author":"Arumugam","year":"2012","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bmj.3.5559.241-a","article-title":"Oculogyric crises due to phenothiazines","volume":"3","author":"Harries","year":"1967","journal-title":"Br. Med. J."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2169\/internalmedicine.47.0623","article-title":"Acute oculogyric crisis in a patient taking clebopride","volume":"47","author":"Kim","year":"2008","journal-title":"Intern Med."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/EJA.0000000000000169","article-title":"Ondansetron-induced oculogyric crisis","volume":"31","author":"Macachor","year":"2014","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2044.1987.tb04081.x","article-title":"Oculogyric crisis after day case anaesthesia","volume":"42","author":"Dingwall","year":"1987","journal-title":"Anaesthesia"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archneur.1979.00500440092024","article-title":"Carbamazepine-induced oculogyric crisis","volume":"36","author":"Berchou","year":"1979","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1528-1157.1995.tb00477.x","article-title":"Oculogyric crisis induced by carbamazepine","volume":"36","author":"Gorman","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3171\/JNS\/2008\/109\/11\/0944","article-title":"Oculogyric crisis masquerading as ventriculoperitoneal shunt dysfunction","volume":"109","author":"AlAzwary","year":"2008","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/088307388600100313","article-title":"Oculogyric crisis: a distinct toxic effect of carbamazepine","volume":"1","author":"Arnstein","year":"1986","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib36","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1111\/j.1528-1167.2010.02967.x","article-title":"Oculogyric crises secondary to lamotrigine overdosage","volume":"52","author":"Veerapandiyan","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib37","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1528-1157.1996.tb00537.x","article-title":"Movement disorders associated with the use of gabapentin","volume":"37","author":"Reeves","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib38","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.52.9.1918","article-title":"Elimination of oxcarbazepine-induced oculogyric crisis following vagus nerve stimulation","volume":"52","author":"Gatzonis","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003246-200202000-00033","article-title":"Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy","volume":"30","author":"Chechani","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4103\/0253-7613.117760","article-title":"Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder","volume":"45","author":"Tikka","year":"2013","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000091840","article-title":"Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine","volume":"140","author":"Patel","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1017\/S1461145707007791","article-title":"Imipramine, methylphenidate and valproic acid-related EPS in a child: a case report","volume":"10","author":"Tahiroglu","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9394(03)00869-9","article-title":"Oculogyric crisis in patients taking cetirizine","volume":"137","author":"Fraunfelder","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0161-813X(01)00044-4","article-title":"Acetylcholinesterase inhibition and the extrapyramidal syndrome: a review of the neurotoxicity of organophosphate","volume":"22","author":"Hsieh","year":"2001","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/NDT.S98694","article-title":"Tetrabenazine-induced oculogyric crisis - a rare complication in the treatment of Gilles de la Tourette syndrome","volume":"12","author":"Janik","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib46","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.34.5.688","article-title":"Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome","volume":"34","author":"Jankovic","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/mds.870130421","article-title":"Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease","volume":"13","author":"LeWitt","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000115684","article-title":"Oculogyric crisis induced by lithium carbonate","volume":"23","author":"Sandyk","year":"1984","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF00920069","article-title":"Oculogyric crisis after the Tensilon test","volume":"228","author":"Nucci","year":"1990","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/PEC.0b013e31823f252d","article-title":"Cefixime-induced oculogyric crisis","volume":"28","author":"Bayram","year":"2012","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib51","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/106002809302700710","article-title":"Oculogyric crisis possibly related to pentazocine","volume":"27","author":"Burstein","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1192\/bjp.150.1.127","article-title":"Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime","volume":"150","author":"Singh","year":"1987","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0190-9622(88)70078-X","article-title":"Adverse reactions to isotretinoin. A report from the adverse drug reaction reporting system","volume":"18","author":"Bigby","year":"1988","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib54","first-page":"506301","article-title":"Phencyclidine induced oculogyric crisis responding well to conventional treatment","volume":"2015","author":"Tahir","year":"2015","journal-title":"Case Rep. Emerg. Med."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib55","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1651-2227.1997.tb08902.x","article-title":"Salicylate intoxication using a skin ointment","volume":"86","author":"Chiaretti","year":"1997","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1176\/jnp.2006.18.3.424","article-title":"Isolated oculogyric crisis on clozapine discontinuation","volume":"18","author":"Mendhekar","year":"2006","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1212\/01.wnl.0000180349.84136.e1","article-title":"Oculogyric dystonic states in early-onset parkinsonism with basal ganglia calcifications","volume":"65","author":"Kis","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib58","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2169\/internalmedicine.53.1233","article-title":"Parkinson's disease presenting with oculogyric crisis in the off period","volume":"53","author":"Furuta","year":"2014","journal-title":"Intern Med."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/WNL.0b013e3181e620ae","article-title":"Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency","volume":"75","author":"Brun","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10545-009-1076-1","article-title":"Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up","volume":"32","author":"Manegold","year":"2009","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"Suppl 6","key":"10.1016\/j.parkreldis.2016.11.012_bib61","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1002\/ana.10631","article-title":"Aromatic L-amino acid decarboxylase deficiency: overview of clinical features and outcomes","volume":"54","author":"Swoboda","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.22685","article-title":"Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy","volume":"71","author":"Friedman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib63","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ane.12230","article-title":"Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene","author":"Koht","year":"2014","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib64","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/brain\/awp084","article-title":"Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia","volume":"132","author":"Clot","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib65","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/brain\/awh603","article-title":"Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder","volume":"128","author":"Neville","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib66","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/clinchem\/45.12.2073","article-title":"Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency","volume":"45","author":"Brautigam","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib67","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/mds.10095","article-title":"Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy","volume":"17","author":"Grattan-Smith","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.02.001","article-title":"Tyrosine hydroxylase deficiency with severe clinical course","volume":"97","author":"Zafeiriou","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib69","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/mds.23002","article-title":"Tyrosine hydroxylase deficiency in three Greek patients with a common ancestral mutation","volume":"25","author":"Pons","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib70","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.18295\/2075-0528.1606","article-title":"A\u00a0new tyrosine hydroxylase genotype with orofacial dyskinaesia","volume":"14","author":"Al-Muslamani","year":"2014","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2008.01.003","article-title":"Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms","volume":"94","author":"Horvath","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/mds.870080228","article-title":"Effect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia","volume":"8","author":"Lamberti","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.870050303","article-title":"Rett syndrome and associated movement disorders","volume":"5","author":"FitzGerald","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10545-015-9897-6","article-title":"Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder","volume":"39","author":"Jacobsen","year":"2016","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib75","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa1207281","article-title":"Brain dopamine-serotonin vesicular transport disease and its treatment","volume":"368","author":"Rilstone","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib76","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.20511","article-title":"Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia","volume":"20","author":"Williams","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib77","doi-asserted-by":"crossref","first-page":"371256","DOI":"10.1155\/2014\/371256","article-title":"Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review","volume":"2014","author":"Yang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib78","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/mds.22876","article-title":"Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia","volume":"25","author":"Lai","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib79","first-page":"244","article-title":"Neuronal intranuclear hyaline inclusion disease associated with premature coronary atherosclerosis","volume":"7","author":"Parker","year":"1987","journal-title":"J.\u00a0Clin. Neuroophthalmol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib80","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2013.10.016","article-title":"Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia","volume":"20","author":"Virmani","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0887-8994(90)90030-5","article-title":"Osmiophilic deposits in cytosomes in Hallervorden-Spatz syndrome","volume":"6","author":"Zupanc","year":"1990","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib82","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/epi.12987","article-title":"GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders","volume":"56","author":"Ohba","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-2005-865715","article-title":"Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). Report of a new case","volume":"36","author":"Mercimek-Mahmutoglu","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-014-1279-x","article-title":"Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings","volume":"128","author":"Oblak","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib85","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.parkreldis.2014.01.010","article-title":"Expansion of the clinicopathological and mutational spectrum of Perry syndrome","volume":"20","author":"Chung","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0404.1994.tb01657.x","article-title":"Adult Chediak-Higashi syndrome presenting as parkinsonism and dementia","volume":"89","author":"Uyama","year":"1994","journal-title":"Acta Neurol. Scand."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2016.11.012_bib87","first-page":"321","article-title":"Movement disorders in ataxia-teleangiectasia: review of six patients","volume":"39","author":"Urra","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mds.21177","article-title":"Smoking-responsive juvenile-onset parkinsonism","volume":"22","author":"Hanagasi","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib89","first-page":"724","article-title":"Postencephalitic paroxysmal oculogyric crises: report of cases","volume":"33","author":"Cheney","year":"1930","journal-title":"Cal. West Med."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib90","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.1.4195.816","article-title":"Effect of benzedrine on the oculogyric crises of parkinsonism","volume":"1","author":"Hoffman","year":"1941","journal-title":"Br. Med. J."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib91","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/1353-8020(96)00005-3","article-title":"Adolf hitler had post-encephalitic parkinsonism","volume":"2","author":"Lieberman","year":"1996","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib92","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/brain\/84.3.395","article-title":"Crises in post-encephalitic parkinsonism","volume":"84","author":"Onuaguluchi","year":"1961","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archneur.1983.04050010056014","article-title":"Oculogyric crises and parkinsonism. A case of recent onset","volume":"40","author":"Clough","year":"1983","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib94","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/mds.21664","article-title":"Contemporary encephalitis lethargica presenting with agitated catatonia, stereotypy, and dystonia-parkinsonism","volume":"22","author":"Dale","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib95","first-page":"1521","article-title":"Encephalitis lethargica like illness: case report and literature review","volume":"89","author":"Sridam","year":"2006","journal-title":"J.\u00a0Med. Assoc. Thai"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib96","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1531-8257(200011)15:6<1168::AID-MDS1016>3.0.CO;2-V","article-title":"Markedly severe dystonia in Japanese encephalitis","volume":"15","author":"Kalita","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib97","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000105093","article-title":"Parkinsonism with oculogyric crises; stimulation and partial elimination of periaqueductal grey and mesencephalic tegmentum (tegmentotomy)","volume":"18","author":"Wycis","year":"1958","journal-title":"Confin. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib98","first-page":"233","article-title":"Oculomotor characteristics of parkinsonism in comparison with those of cerebellar ataxia","volume":"19","author":"Shimizu","year":"1983","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib99","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/mds.1057","article-title":"Oculogyric-like crises in a 92-year-old woman with vascular Parkinsonism","volume":"16","author":"Scarmeas","year":"2001","journal-title":"Mov. Disord."},{"issue":"Pt 6","key":"10.1016\/j.parkreldis.2016.11.012_bib100","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/brain\/117.6.1457","article-title":"Abnormal eye movements in blepharospasm and involuntary levator palpebrae inhibition. Clinical and pathophysiological considerations","volume":"117","author":"Aramideh","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib101","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/mds.21841","article-title":"Extraocular muscle dystonia due to acquired (non-Wilsonian) hepatocerebral degeneration","volume":"23","author":"Ferrara","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib102","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(16)00126-5","article-title":"Functional (psychogenic) saccadic oscillations and oculogyric crises","volume":"15","author":"Baizabal-Carvallo","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib103","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneurol.2011.27","article-title":"Oculogyric crisis in a midbrain lesion","volume":"68","author":"Della Marca","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib104","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3171\/jns.1988.69.6.0951","article-title":"Positional oculogyric crises. Case report","volume":"69","author":"Heimburger","year":"1988","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib105","first-page":"198","article-title":"Delayed oculogyric crises associated with striatocapsular infarction","volume":"11","author":"Liu","year":"1991","journal-title":"J.\u00a0Clin. Neuroophthalmol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib106","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1360-0443.1999.94343113.x","article-title":"Subacute onset of oculogyric crises and generalized dystonia following intranasal administration of heroin","volume":"94","author":"Schoser","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib107","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/mds.870110632","article-title":"Oculogyric crisis and abnormal magnetic resonance imaging signals in bilateral lentiform nuclei","volume":"11","author":"Kim","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib108","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4065\/78.9.1150","article-title":"Ondansetron-induced multifocal encephalopathy","volume":"78","author":"Ritter","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib109","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-8994(98)00148-9","article-title":"Posterior leukoencephalopathy syndrome may not be reversible","volume":"20","author":"Antunes","year":"1999","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib110","series-title":"Ocular Deviations. System of Ophthalmology","author":"Duke-Elder","year":"1971"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib111","series-title":"Postencephalitic Parkinsonism","author":"Henry","year":"2003"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib112","series-title":"The Pathophys of Extrapyramidal Side Effects of Neuroleptic Drugs","author":"Marsden","year":"1980"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib113","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuron.2013.12.027","article-title":"Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling","volume":"81","author":"Chuhma","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuron.2016.06.014","article-title":"Parkinsonism driven by antipsychotics originates from dopaminergic control of striatal cholinergic interneurons","volume":"91","author":"Kharkwal","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib115","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/mds.25107","article-title":"Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis","volume":"27","author":"Teo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib116","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1476-5381.1995.tb16684.x","article-title":"Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area","volume":"116","author":"Prisco","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib117","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hup.325","article-title":"A\u00a0critical review of akathisia, and its possible association with suicidal behaviour","volume":"16","author":"Hansen","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib118","first-page":"393","article-title":"Serotonin in the basal ganglia: functions and interactions with other neuronal pathways","volume":"77","author":"Dray","year":"1981","journal-title":"J.\u00a0Physiol. (Paris)"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib119","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13311-013-0240-3","article-title":"Treatment of movement disorder emergencies","volume":"11","author":"Frucht","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.319.7210.623","article-title":"Acute dystonia induced by drug treatment","volume":"319","author":"van Harten","year":"1999","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2016.11.012_bib121","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1177\/07067437980430S105","article-title":"Assessment and management of antipsychotic-induced adverse events","volume":"43","author":"Cortese","year":"1998","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib122","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0361-1124(79)80059-3","article-title":"Treatment of drug-induced dystonic reactions","volume":"8","author":"Lee","year":"1979","journal-title":"JACEP"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib123","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1600-0447.1989.tb03016.x","article-title":"Effect of clonazepam on neuroleptic-induced oculogyric crisis","volume":"80","author":"Horiguchi","year":"1989","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib124","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/mds.870120403","article-title":"The emerging role of clozapine in the treatment of movement disorders","volume":"12","author":"Factor","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4088\/JCP.v58n0706","article-title":"Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients","volume":"58","author":"Spivak","year":"1997","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.11.012_bib126","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1345\/aph.1K250","article-title":"Clozapine-induced oculogyric crises","volume":"41","author":"Chakraborty","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib127","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00044011-200727120-00009","article-title":"Tardive oculogyric crisis during treatment with clozapine: report of three cases","volume":"27","author":"Uzun","year":"2007","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.parkreldis.2016.11.012_bib128","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/0253-7176.162946","article-title":"Oculogyric crisis with clozapine: a case report and review of similar case reports in the literature","volume":"37","author":"Nebhinani","year":"2015","journal-title":"Indian J. Psychol. Med."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016304576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016304576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:35:46Z","timestamp":1749760546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016304576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":128,"alternative-id":["S1353802016304576"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.11.012","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oculogyric crises: Etiology, pathophysiology and therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}